Regorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal Adenocarcinomas

Clinical trial NCT03722108 · TERMINATED

Trial details

NCT number: NCT03722108
Sponsor: UNICANCER
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Stomach Adenocarcinoma of the Gastroesophageal Junction

Start date: 2019-02-07
Primary completion: 2022-05-19
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.